Document:

Exhibit

Exhibit 10.1
ADDENDUM TO SETTLEMENT AGREEMENT
KEMET Corporation and KEMET Electronics Corporation (together “KEMET”) and Plaintiffs Chip-Tech, Ltd., Dependable Component Supply Corp., eIQ Energy, Inc., and Walker Component Group, Inc. (together, the “Direct Purchaser Plaintiffs”), individually and on behalf of the direct purchaser Class, entered into the Settlement Agreement on November 8, 2019 to settle the Released Claims.  
On January 6, 2020, Direct Purchaser Plaintiffs filed a motion seeking preliminary approval of their settlement with KEMET. 
On January 23, 2020, the Court held a hearing on Direct Purchaser Plaintiffs’ motion for preliminary approval and ordered that the Class be provided with an opportunity to opt out of the settlement and that Direct Purchaser Plaintiffs add a deadline for filing a claim to the schedule.
1.All capitalized terms used in this Addendum to Settlement Agreement shall have the same meanings as in the Settlement Agreement unless otherwise specifically defined herein.
2.Any Class Member that wishes to seek exclusion from the settlement class by “opting out” must timely submit a written request for Exclusion to the Claims Administrator (a “Request for Exclusion”).  To be effective, such a Request for Exclusion must state: the Class Member’s full legal name, address, and telephone number; that the Class Member purchased Capacitors directly from one or more of the Defendants during the Class Period; and that the Class Member (1) wants to be excluded from the In re Capacitors Antitrust Litigation class action settlement with KEMET and (2) understands that by so doing, the Class member will not be able to get any money or benefits from the settlement with KEMET under the Settlement Agreement.  All Requests for Exclusion must be signed and dated by the Class Member or its officer or legal representative, and must be (1) mailed to the Claims Administrator via First Class United States Mail (or United States Mail for overnight delivery), postmarked by March 26, 2020, and received by the Claims Administrator on or before April 6, 2020; or (2) submitted online at www.capacitorsantitrustsettlement.com by March 26, 2020.  The Claims Administrator shall provide to counsel for KEMET all Requests for Exclusion and documents submitted therewith, and the Claims Administrator shall prepare a summary of the opt outs to be filed with the Court.  With the Motion for Final Approval, Class Counsel will file with the Court a 

1 

complete list of Requests for Exclusion from the settlement class, including only the name, city and state of the Person requesting exclusion.  Persons who opt out are not entitled to any monetary award from the Settlement Fund.
3.By April 6, 2020, or within seven (7) days of receipt by the Claims Administrator of any Request for Exclusion submitted by a Class Member pursuant to Paragraph 2 herein, whichever is later, Class Counsel shall inform counsel for KEMET of (1) the name of each Class Member that submitted a Request for Exclusion; (2) the amount (in U.S. dollars) of the U.S. Purchases during the Class Period of each Class Member that submitted a Request for Exclusion; and (3) the amount (in U.S. dollars) of U.S. Purchases during the Class Period by all Class Members.  In calculating those amounts and determining the billing and shipping addresses of U.S. Purchases, Class Counsel shall use the data available to Direct Purchaser Plaintiffs in the Action (as produced by Defendants or from any other source).
4.KEMET, in its sole discretion, shall have the option to rescind and terminate the Settlement Agreement in its entirety and without liability of any kind if the aggregate amount (in U.S. dollars) of U.S. Purchases by Class Members that submit a Request for Exclusion is equal to or greater than 10% of the amount (in U.S. dollars) of U.S. Purchases during the Class Period by all Class Members.  KEMET shall exercise this option to rescind and terminate the Settlement Agreement by providing written notice to Class Counsel no later than fourteen (14) calendar days after receipt of the information to be provided by Class Counsel pursuant to Paragraph 3 herein, or fourteen (14) calendar days after the Motion for Final Approval is filed, whichever is later.  Such notice, if given, shall be in the form prescribed by Paragraph 52 of the Settlement Agreement.  Upon such rescission and termination, Direct Purchaser Plaintiffs and KEMET will notify the Court immediately and withdraw all pending motions filed to effectuate the settlement.  In the event that KEMET exercises this option to rescind and terminate the Settlement Agreement, Paragraph 34 of the Settlement Agreement shall apply in the same manner as if the Settlement Agreement had been rescinded pursuant to Paragraph 33 of the Settlement Agreement.

2 

IN WITNESS WHEREOF, the parties hereto, through their fully authorized representatives, have agreed to this Addendum to Settlement Agreement as of February 3, 2020.

	
			
	By: /s/ JOSEPH R. SAVERI
	 
	By: /s/ JACOB R. SORENSEN

	 
	 
	 

	Joseph R. Saveri
	 
	Roxane A. Polidora

	Joseph Saveri Law Firm, Inc.
	 
	Jacob R. Sorensen

	555 Montgomery Street
	 
	Pillsbury Winthrop Shaw Pittman LLP

	Suite 1210
	 
	Four Embarcadero Center, 22nd Floor

	San Francisco, CA 94111
	 
	San Francisco, CA 94111

	 
	 
	 

	Class Counsel
	 
	Counsel for

	for Direct Purchaser Plaintiffs
	 
	KEMET Corporation and

	 
	 
	KEMET Electronics Corporation

3nbix-ex44_74.htm

Exhibit 4.4

DESCRIPTION OF COMMON STOCK

The following summary description of the common stock of Neurocrine Biosciences, Inc., or we, our or us is based on the provisions of our certificate of incorporation, as amended, as well as our bylaws, as amended, and the applicable provisions of the Delaware General Corporation Law. This information is qualified entirely by reference to the applicable provisions of our certificate of incorporation, as amended, bylaws, as amended, and the Delaware General Corporation Law. Our certificate of incorporation, as amended, and bylaws, as amended, have previously been filed as exhibits with the Securities and Exchange Commission.

Common Stock

Voting. Common stockholders are entitled to one vote per share for the election of directors and on all other matters that require stockholder approval, and do not have cumulative voting rights.

Dividends and Other Distributions. Subject to any preferential rights of outstanding preferred stock, holders of our common stock are entitled to share ratably in any dividends declared by our board of directors on the common stock and paid out of funds legally available for such dividends.

Distribution on Dissolution. Subject to any preferential rights of outstanding preferred stock, in the event of our liquidation, dissolution or winding up, holders of our common stock are entitled to share ratably in any assets remaining after payment of liabilities and the liquidation preferences of any outstanding preferred stock.

Other Rights. Our common stock does not carry any preemptive rights enabling a holder to subscribe for, or receive shares of, any class of our common stock or any other securities convertible into shares of any class of our common stock. There are no redemption rights or sinking fund provisions applicable to our common stock.

Anti-takeover Effects of Provisions of Delaware Law and Charter Documents

Delaware Anti-Takeover Law

We are subject to Section 203 of the Delaware General Corporation Law, or Section 203. Section 203 generally prohibits a public Delaware corporation from engaging in a “business combination” with an “interested stockholder” for a period of three years after the date of the transaction in which the person became an interested stockholder, unless:

 

	
 
	
•
	
 
	
prior to the date of the transaction, the board of directors of the corporation approved either the business combination or the transaction which resulted in the stockholder becoming an interested stockholder;

 

	
 
	
•
	
 
	
the interested stockholder owned at least 85% of the voting stock of the corporation outstanding upon consummation of the transaction, excluding for purposes of determining the number of shares outstanding (a) shares owned by persons who are directors and also officers and (b) shares owned by employee stock plans in which employee participants do not have the right to determine confidentially whether shares held subject to the plan will be tendered in a tender or exchange offer; or

 

	
 
	
•
	
 
	
on or subsequent to the consummation of the transaction, the business combination is approved by the board and authorized at an annual or special meeting of stockholders, and not by written consent, by the affirmative vote of at least 66 2/3% of the outstanding voting stock which is not owned by the interested stockholder.

Section 203 defines a business combination to include:

 

	
 
	
•
	
 
	
any merger or consolidation involving the corporation and the interested stockholder;

 

	
 
	
•
	
 
	
any sale, transfer, pledge or other disposition involving the interested stockholder of 10% or more of the assets of the corporation;

 

 

 

	
 
	
•
	
 
	
subject to exceptions, any transaction involving the corporation that has the effect of increasing the proportionate share of the stock of any class or series of the corporation beneficially owned by the interested stockholder;

 

	
 
	
•
	
 
	
subject to exceptions, any transaction that results in the issuance or transfer by the corporation of any stock of the corporation to the interested stockholder; and

 

	
 
	
•
	
 
	
the receipt by the interested stockholder of the benefit of any loans, advances, guarantees, pledges or other financial benefits provided by or through the corporation.

In general, Section 203 defines an interested stockholder as any entity or person beneficially owning 15% or more of the outstanding voting stock of the corporation and any entity or person affiliated with or controlling or controlled by the entity or person.

Certificate of Incorporation

Our certificate of incorporation, as amended, (i) provides for a board comprised of three classes of directors with each class serving a staggered three-year term, (ii) authorizes our board of directors to issue preferred stock from time to time, in one or more classes or series, without stockholder approval, (iii) requires the approval of at least two-thirds of the outstanding voting stock to amend certain provisions of our certificate of incorporation, as amended, and our bylaws, as amended, and (iv) does not include a provision for cumulative voting for directors. Under cumulative voting, a minority stockholder holding a sufficient percentage of a class of shares may be able to ensure the election of one or more directors. These and other provisions contained in our certificate of incorporation, as amended, and bylaws, as amended, could delay or discourage transactions involving an actual or potential change in control of us or our management, including transactions in which stockholders might otherwise receive a premium for their shares over then current prices. Such provisions could also limit the ability of stockholders to remove current management or approve transactions that stockholders may deem to be in their best interests and could adversely affect the price of our common stock.

Transfer Agent and Registrar

The transfer agent and registrar for our common stock is American Stock Transfer & Trust Company, LLC. The transfer agent and registrar’s address is 59 Maiden Lane, New York, New York 10038. 

Listing on the Nasdaq Global Select Market

Our common stock is listed on the Nasdaq Global Select Market under the symbol NBIX.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00304-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00304-of-00352.parquet"}]]